Abdelrahman Ibrahim Abushouk, Amr Muhammad Abdo Salem, Anas Saad, Ahmed M. Afifi, Abdelrahman Yousry Afify, Hesham Afify, . . . Mohamed M. Abdel-Daim. (2019). Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate. Frontiers Media S.A..
Chicago Style (17th ed.) CitationAbdelrahman Ibrahim Abushouk, Amr Muhammad Abdo Salem, Anas Saad, Ahmed M. Afifi, Abdelrahman Yousry Afify, Hesham Afify, Hazem S.E. Salem, Esraa Ghanem, and Mohamed M. Abdel-Daim. Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate. Frontiers Media S.A., 2019.
MLA (9th ed.) CitationAbdelrahman Ibrahim Abushouk, et al. Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate. Frontiers Media S.A., 2019.